Table 1.
eMERGE cohort | PHOEBE cohort | Cohort overlap | ||||||
---|---|---|---|---|---|---|---|---|
Patients with subsequent treatment | Total | PPV | Patients with subsequent treatment | Total | PPV | |||
Diabetes mellitus type I | CUIMC | 7,599 | 25,701 | 0.34 | 7,659 | 25,884 | 0.34 | 25,635 |
MDCD | 25,954 | 191,710 | 0.13 | 26,240 | 194,100 | 0.13 | 189,810 | |
MDCR | 19,274 | 185,874 | 0.10 | 18,684 | 181,712 | 0.11 | 179,236 | |
Diabetes mellitus type II | CUIMC | 42,200 | 211,904 | 0.20 | 44,828 | 218,127 | 0.21 | 211,903 |
MDCD | 342,975 | 1,807,688 | 0.19 | 383,435 | 1,849,177 | 0.21 | 1,807,019 | |
MDCR | 105,449 | 386,265 | 0.27 | 804,415 | 2,172,925 | 0.37 | 386,237 | |
ADHD | CUIMC | 5,922 | 29,890 | 0.20 | 7,002 | 35,291 | 0.20 | 29,890 |
MDCD | 722,485 | 1,471,559 | 0.49 | 809,093 | 1,657,347 | 0.49 | 1,471,542 | |
MDCR | 7,158 | 17,065 | 0.42 | 7,875 | 18,535 | 0.43 | 17,065 | |
Heart Failure | CUIMC | 71,281 | 162,297 | 0.44 | 74,121 | 168,111 | 0.44 | 162,281 |
MDCD | 332,929 | 870,080 | 0.38 | 342,112 | 893,807 | 0.38 | 869,500 | |
MDCR | 892,689 | 1,166,980 | 0.76 | 919,077 | 1,204,488 | 0.76 | 1,165,900 |